As part of our Framework for Growth, Biogen Idec is renewing its commitment to scientific innovation in the pursuit of new therapies for Progressive MS and other important Neurodegenerative Diseases, including Alzheimer’s Disease, Parkinson’s Disease, ALS, and others. With this renewed commitment, we are expanding our Neurology Discovery and Translational Medicine teams, which use cutting edge research and imaging technologies to investigate novel disease pathways, identify new drug candidates, and establish novel translational strategies to improve the likelihood of drug development success in neurodegenerative diseases.
To support our growth in Neurology R&D, we are hiring senior investigators and research associates in the following areas:
- Myelin Repair
- Synaptic Plasticity
- Protein misfolding
- Translational Neuroimaging
- Behavioral Neuroscience
- Blood Brain Barrier Transport
- In vitro assay development
Neurology R&D Mission:
Through cutting-edge science and translational research, we will efficiently discover and develop innovative new drug candidates for the treatment of progressive MS and other neurodegenerative diseases.